This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Erectile Dysfunction industry.
What is the current market size of the erectile dysfunction industry, and what growth rate is it expected to achieve?
The erectile dysfunction market size has grown strongly in recent years. It will grow from $2.46 billion in 2024 to $2.69 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to the rising incidence of cardiovascular diseases, increasing prevalence of diabetes, growing awareness of erectile dysfunction as a medical condition, an aging population leading to higher erectile dysfunction cases, and rising preference for personalized treatment options.
The erectile dysfunction market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to an increase in psychological factors, higher rates of obesity and metabolic disorders, growing demand for non-invasive erectile dysfunction treatments, an increase in patient consultations for sexual health, and increasing government initiatives to promote men’s health and lifestyle-related risk factors. Major trends in the forecast period include the expansion of e-pharmacies for erectile dysfunction drugs, advancements in penile implant technologies, technological advancements in erectile dysfunction diagnostics, innovative treatment methods targeting root causes of erectile dysfunction, and the introduction of effective phosphodiesterase type 5 inhibitors.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21185&type=smp
What are the major drivers contributing to the growth of the erectile dysfunction market?
The rising prevalence of lifestyle-related diseases is expected to drive the erectile dysfunction market. Lifestyle-related diseases are health conditions primarily caused by unhealthy habits, such as poor diet, lack of exercise, smoking, and excessive alcohol consumption. The increase in lifestyle-related diseases is due to rising sedentary behavior, poor dietary habits, stress, and unhealthy habits like smoking and excessive alcohol consumption. Erectile dysfunction (ED) serves as an early warning sign for lifestyle-related diseases, such as cardiovascular conditions and diabetes, highlighting the need for timely medical intervention and healthier lifestyle choices. For instance, in May 2022, according to the report published by the World Obesity Federation, a UK-based non-profit organization, by 2030, one billion people globally, including 1 in 5 women and 1 in 7 men, are projected to live with obesity, increasing to 4 billion people, or 51% of the global population, living either overweight or obese by 2035. Therefore, the rising prevalence of lifestyle-related diseases will propel growth of the erectile dysfunction market.
What are the major market segments driving the growth of the erectile dysfunction industry?
The erectile dysfunction market covered in this report is segmented –
1) By Product: Drugs, Devices
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channels
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Pharmacies, Other End Users
Subsegments:
1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors, Hormone Therapy, Injectable Medications, Topical Medications
2) By Devices: Vacuum Erection Devices (VEDs), Penile Implants, Shockwave Therapy Devices
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/erectile-dysfunction-global-market-report
Which sustainability trends are emerging in the erectile dysfunction market?
Major companies operating in the erectile dysfunction market are focusing on innovative products, such as over-the-counter (OTC) gel, to provide more accessible and convenient treatment options for individuals experiencing erectile dysfunction, thereby expanding their market reach and addressing unmet patient needs. An over-the-counter (OTC) gel is a topical medication available without a prescription, used for treating various conditions directly applied to the skin. For instance, in September 2024, Haleon plc, a UK-based consumer healthcare company, launched Eroxon, the first FDA-cleared over-the-counter gel for erectile dysfunction (ED). This innovative product offers a non-invasive, fast-acting solution for ED, designed to provide enhanced accessibility and convenience for patients. Its ease of use, offering a topical application that eliminates the need for oral medications, reducing potential systemic side effects.
Who are the key market players contributing to the growth of the erectile dysfunction industry?
Major companies operating in the erectile dysfunction market are Pfizer Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Limited, Boston Scientific Corporation, Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Coloplast Corporation, Dr. Reddy’s Laboratories Limited, Cipla Limited, Ferring Pharmaceuticals A/S, Endo International plc, Zydus Lifesciences Limited, Lupin Limited, Hims & Hers Health Inc., Cadila Pharmaceuticals Limited, VIVUS Inc., Rigicon Inc., Petros Pharmaceuticals Inc., Futura Medical plc, Apricus Biosciences Inc., Pos-T-Vac Medical Inc., Initiator Pharma A/S
Which regions are leading the growth of the erectile dysfunction market globally?
North America was the largest region in the erectile dysfunction market in 2024. The regions covered in the erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Erectile Dysfunction Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21185
Need Customized Data On Erectile Dysfunction Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=21185&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
